Patients Patient involvement at NICE: In whose interest is it anyway? The National Institute for Health and Care Excellence (NICE) released a new
Views & Analysis Patient involvement in HTA Considering the essential role of patient experience in HTA and the role of pharma.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
